Co-Diagnostics, Inc. (CODX) vs Vivos Therapeutics, Inc. (VVOS)
- Co-Diagnostics, Inc. CODX 0.65 −9.72%
- Vivos Therapeutics, Inc. VVOS 0.13 −7.14%
Co-Diagnostics, Inc. and Vivos Therapeutics, Inc. are both Medical Devices companies. Co-Diagnostics, Inc. is the larger, with a market value of $5.3M against $4.8M — 1.1× the size. Vivos Therapeutics, Inc. grew revenue faster over the last twelve months: 45.2% against −28.1%. Vivos Therapeutics, Inc. has the higher net margin (−121.8% vs −6,522.9%) and the lower return on invested capital (−592.7% vs −337.7%). Across the 17 metrics below, Vivos Therapeutics, Inc. leads on 14 and Co-Diagnostics, Inc. on 3.
Valuation
Profitability
| Metric | CODX | VVOS | Medical Devices median |
|---|---|---|---|
| Gross margin | 43.47% | 61.89% | 56.01% |
| Operating margin | (6,787.47%) | (107.89%) | (15.03%) |
| Net margin | (6,522.91%) | (121.79%) | (20.40%) |
| Free cash flow margin | (3,807.94%) | (90.97%) | (7.24%) |
| Return on equity | (174.77%) | 10,022.05% | (15.32%) |
| Return on assets | (149.25%) | (101.46%) | (19.72%) |
| Return on invested capital | (337.68%) | (592.70%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack